Synbiotic vs placebo or no treatment
- Synbiotics, prebiotics and probiotics for people with chronic kidney disease 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 23 participantsVery low
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether probiotic changes change in any GI upset or intolerance (abdominal pain/diarrhoea) compared with placebo or no treatment (very low certainty).
It is very uncertain whether probiotic changes change in any GI upset or intolerance (constipation) compared with placebo or no treatment (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The intervention showed no clear difference in all‐cause mortality (low certainty).
The intervention showed no clear difference in cardiovascular‐related mortality (low certainty).
The review found no eligible studies for this question.
The intervention showed no clear difference in all‐cause hospital admission (number of participants with at least… (low certainty).
The intervention may leads to lower cardiovascular‐related hospital admission (number of events) (low certainty).
The intervention showed no clear difference in cardiovascular‐related hospital admission (number of participants… (low certainty).